Medikinet Xl (Methylphenidate Hydrochloride)

Methylphenidate hydrochloride blocks the reuptake of dopamine and norepinephrine, increasing their levels in the brain. This heightened neurotransmitter activity enhances attention, impulse control, and alertness, which underlies its therapeutic effects in ADHD and narcolepsy.

The appropriate dose of Medikinet XL is determined individually by a qualified prescriber based on the patient’s age, clinical response, and tolerability. Dosage adjustments are made according to therapeutic goals and any observed side effects.

Safety data for methylphenidate during pregnancy and lactation are limited. Prescribers should weigh potential benefits against possible risks and consider alternative treatments when possible. Women who are pregnant, planning pregnancy, or breastfeeding should discuss options with their healthcare provider.

To request Medikinet XL, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Medikinet XL is an extended‑release formulation of methylphenidate, offering once‑daily dosing and a smoother plasma concentration profile compared with immediate‑release stimulants. It provides comparable efficacy to other methylphenidate products but may differ in duration of action and side‑effect profile from atomoxetine or amphetamine‑based agents.

Store Medikinet XL at ambient temperature, below 25 °C, in the original container. Protect the tablets from moisture and direct sunlight to maintain stability and potency throughout the shelf life.

Medikinet XL tablets are taken orally, usually in the morning with or without food, as directed by the prescriber. The tablet should be swallowed whole and not split, chewed, or crushed to preserve the extended‑release properties.

Serious risks include cardiovascular events such as hypertension or tachycardia, emergence of psychotic symptoms, and severe allergic reactions. Patients should be monitored regularly for these events, and any sudden chest pain, mood changes, or signs of an allergic reaction require immediate medical attention.

Medikinet XL is contraindicated in individuals with known hypersensitivity to methylphenidate or any tablet components, those currently taking monoamine oxidase inhibitors, and patients with severe anxiety, agitation, glaucoma, or significant cardiovascular disease unless specifically advised by a physician.